Calcium fructoborate may boost effectiveness of glucosamine + chondroitin, says new study

By Stephen DANIELLS

- Last updated on GMT

Calcium fructoborate may boost effectiveness of glucosamine + chondroitin, says new study

Related tags: Chondroitin sulfate

Combining calcium fructoborate with glucosamine and chondroitin may boost measure of joint health by about 25% compared with glucosamine and chondroitin alone, says a new study from VDF Futureceuticals.

The mineral complex - marketed as FruiteX-B and manufactured under US patent #5,962,049 - contains boron, calcium and fructose, and was found to improve scores of joint health and pain by 24% and 25%, respectively, when used in combination with glucosamine and chondroitin, according to findings published in the Journal of Aging Research and Clinical Practice.

The study was performed by scientists from FutureCeuticals Inc., the University of California at Irvine, and NutraClinical Inc, and FutureCeuticals funded the study.

Hartley Pond, the company’s Vice President of Sales, welcomed the findings, saying: “This study shows that in the context of the widely used combination of glucosamine and chondroitin, FruiteX-B continues to provide the significant benefits for joint health documented in previous research on this remarkable mineral complex.

“The results in the FruiteX-B, glucosamine, and chondroitin group align with previous studies published earlier this year and in 2012. In all instances, FruiteX-B delivered significant, fast-acting improvement that people feel.”

Study details

The scientists recruited 90 generally healthy people and randomly divided them into three groups: The first group received placebo, the second and third groups received 750 mg per day of glucosamine and 200 mg per day of chondroitin sulfate with or without 110 mg per day of calcium fructoborate.

Subjective testing measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the McGill pain questionnaire.

After 14 days of intervention, results showed that the combination of glucosamine, chondroitin sulfate, and calcium fructoborate results in statistically significant reductions in both WOMAC and McGill scores, but no statistically significant effects were seen in the placebo or glucosamine + chondroitin alone groups.

“Data from our study clearly indicate that short-term use of calcium fructoborate in combination with chondroitin sulfate and glucosamine was effective in reducing knee discomfort and improving the physical mobility of the joints,”​ wrote the researchers. “Future investigations conducted with a larger cohort of subjects and for a longer duration; may provide better understanding of the short and long term effects of supplementation.”

Source: Journal of Aging Research and Clinical Practice
Published online ahead of print, doi:
“Short-term efficacy of a combination of glucosamine and chondroitin sulfate compared to a combination of glucosamine, chondroitin sulfate and calcium fructoborate (CFB) on improvement of knee discomfort conditions in healthy subjects. A comparative, double-blind, placebo controlled acute clinical study”
Authors: Z. Pietrzkowski, M.J. Phelan, R. Keller, C. Shu, R. Argumedo, T. Reyes-Izquierdo

Related news

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Clinically Proven Omega-3 formula for Joint Health

Clinically Proven Omega-3 formula for Joint Health

KD Pharma Group | 01-Sep-2019 | Data Sheet

KD Nutra is pleased to announce the completion of a clinical trial for its Move3™ omega-3 joint formulation. The trial has shown that Move3™ has a significant...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars